A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...
Effect of fusion of radiomic, pathomic, and clinical biomarkers on multi-scale tumor biology and OS stratification in HNSCC receiving standard of care (SOC). Phase 2 trial of ozuriftamab vedotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback